European Commission 16 November 2021, Commission Implementing Regulation (EU) 2022/140 of 16 November 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks (Text with EEA relevance)

Also known as

European Union · · · Cited by 12 · 16-11-2021

Article 1. Subject matter and scope
Article 2. Definitions
Article 3. Biological products to be included in the Union antigen, vaccine and diagnostic reagent banks for certain category A diseases
Article 4. Additional requirements concerning the supply and storage of antigens and vaccines
Article 5. Requirements concerning the formulation of antigens of the foot and mouth disease virus into vaccines and the labelling of the ready-to-use vaccine
Article 6. Procedures for the release and delivery of vaccines
Article 7. Requirements concerning the replacement of antigens, vaccines and diagnostic reagents
Article 8. Procedural and technical requirements for requesting access to the antigens, vaccines and diagnostic reagents from the Union antigen, vaccine and diagnostic reagent banks
Article 9. Entry into force and application
ANNEX I. Biological products to be included in the Union antigen, vaccine and diagnostic reagent banks as referred to in Article 3

2.2.2022

Official Journal of the European Union

L 23/11

COMMISSION IMPLEMENTING REGULATION (EU) 2022/140

of 16 November 2021

laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network (12 references), article-level links and cross-references, which are available to search for free.